Literature DB >> 21680065

Gut derived lactic acid bacteria induce strain specific CD4(+) T cell responses in human PBMC.

Sytze de Roock1, Merel van Elk, Maarten O Hoekstra, Berent J Prakken, Ger T Rijkers, Ismé M de Kleer.   

Abstract

BACKGROUND & AIMS: Probiotic bacteria are used as food supplement in many different disease settings. The immune modulating capacity of different strains is not always properly tested which might result in a suboptimal choice of strains for clinical use.
METHODS: The CD4 T cell responses to 19 different gut derived lactic acid bacteria were tested with different methods to show their diversity in immune modulation and to make a well-founded choice on which strains to use in future clinical trials. After co-culture of PBMC with bacteria, the induction of CD4(+) T cell subsets (regulatory T cells, T helper type (TH)1, TH2 and TH17) was analysed by rtPCR of transcription factor mRNA, intracellular FACS staining of transcription factors and cytokine production.
RESULTS: Bacterial strains all have diverse, unique immune modulatory properties. Strains can induce Treg, TH1, TH2 and TH17 cells which can be shown at different levels of T cell activation, and is consistent for most strains tested. For TH1, TH17 and Treg, a positive correlation between the different methods was found. For TH2 cells the correlation was less consistent.
CONCLUSIONS: Probiotic bacteria have very different immune modulating capacities. Analysis of transcription factor mRNA is a suitable method for in vitro characterization of strains prior to clinical application. 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680065     DOI: 10.1016/j.clnu.2011.05.005

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  9 in total

1.  Lactobacillus fermentum species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota.

Authors:  You Jin Jang; Woon-Ki Kim; Dae Hee Han; Kiuk Lee; Gwangpyo Ko
Journal:  Gut Microbes       Date:  2019-04-03

2.  Differential Metabolism of Exopolysaccharides from Probiotic Lactobacilli by the Human Gut Symbiont Bacteroides thetaiotaomicron.

Authors:  Alicia Lammerts van Bueren; Aakanksha Saraf; Eric C Martens; Lubbert Dijkhuizen
Journal:  Appl Environ Microbiol       Date:  2015-04-03       Impact factor: 4.792

3.  Bifidobacterium breve attenuates murine dextran sodium sulfate-induced colitis and increases regulatory T cell responses.

Authors:  Bin Zheng; Jeroen van Bergenhenegouwen; Saskia Overbeek; Hendrik J G van de Kant; Johan Garssen; Gert Folkerts; Paul Vos; Mary E Morgan; Aletta D Kraneveld
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

4.  Impact of kefir derived Lactobacillus kefiri on the mucosal immune response and gut microbiota.

Authors:  P Carasi; S M Racedo; C Jacquot; D E Romanin; M A Serradell; M C Urdaci
Journal:  J Immunol Res       Date:  2015-02-24       Impact factor: 4.818

Review 5.  The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19.

Authors:  Amin N Olaimat; Iman Aolymat; Murad Al-Holy; Mutamed Ayyash; Mahmoud Abu Ghoush; Anas A Al-Nabulsi; Tareq Osaili; Vasso Apostolopoulos; Shao-Quan Liu; Nagendra P Shah
Journal:  NPJ Sci Food       Date:  2020-10-05

6.  Examining the Gastrointestinal and Immunomodulatory Effects of the Novel Probiotic Bacillus subtilis DE111.

Authors:  Kimberley E Freedman; Jessica L Hill; Yuren Wei; Allegra R Vazquez; Diana S Grubb; Roxanne E Trotter; Scott D Wrigley; Sarah A Johnson; Michelle T Foster; Tiffany L Weir
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

7.  An autologous colonic organoid-derived monolayer model to study immune: bacterial interactions in Crohn's disease patients.

Authors:  Hamish Ck Angus; Paulo Cm Urbano; Gemma A Laws; Shijun Fan; Safina Gadeock; Michael Schultz; Grant Butt; Andrew J Highton; Roslyn A Kemp
Journal:  Clin Transl Immunology       Date:  2022-08-01

Review 8.  Theoretical benefits of yogurt-derived bioactive peptides and probiotics in COVID-19 patients - A narrative review and hypotheses.

Authors:  Ahmed S Gouda; Fatima G Adbelruhman; Hamedah Sabbah Alenezi; Bruno Mégarbane
Journal:  Saudi J Biol Sci       Date:  2021-06-18       Impact factor: 4.052

9.  Interaction with intestinal epithelial cells promotes an immunosuppressive phenotype in Lactobacillus casei.

Authors:  Minna Tiittanen; Joni Keto; Johanna Haiko; Jaana Mättö; Jukka Partanen; Kaarina Lähteenmäki
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.